Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces that the Center for Devices and Radiological Health (CDRH) ...

Recently, news portal Malaysiakini released three pieces of “evidence” from a whistleblower, alleging that the government was involved in abuse of power and corruption. In one of the clips, Sindumin ...

The sNDA was submitted to support full approval of OCA for this indication based on data from the COBALT trial, as well as real-world evidence.

FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and ...

Boston College quarterback Thomas Castellanos will enter the transfer portal after being benched this week, On3 Sports ...

David is the founding publisher and editor of MacroBusiness and was the founding publisher and global economy editor of The ...

NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic ...

The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...

The FDA in 2016 granted accelerated approval to the FXR agonist as a second-line treatment for adults with PBC, either in ...

BOULDER, CO / ACCESSWIRE / November 11, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized ...